Benzinga
FTX Contagion Spreads To Hong Kong Exchange, At Risk Of Capital Deficit
Uber And Lyft NYC Drivers Likely To Get A Pay Boost
Intel Liable To Pay $949M For VLSI Patent Infringement
Target Grapples With Inflation, Q3 Bottomline Takes Huge Hit
- Target Corp (NYSE:TGT) reported third-quarter FY22 sales growth of 3.4% year-on-year to $26.52 billion, beating the consensus of $26.38 billion.
- Comparable sales increased 2.7% on top of 12.7% growth last year.
- The operating margin was 3.9%, and operating income for the quarter declined 49.2% to $1 billion.
FDA Gives Emergency Use Nod To Roche's Monkeypox Test
- FDA has granted Emergency Use Authorization for Roche Holdings AG's RHHBY cobas MPXV for use on the cobas 6800/8800 Systems.
- The test is a real-time PCR test for the qualitative detection of DNA from the monkeypox virus (MPXV) in lesion swabs collected from individuals suspected of monkeypox infection by their healthcare provider.
Restaurant Brands Appoints Former Domino's CEO Patrick Doyle As Chair
Lowe's Q3 Earnings Edge Out Analysts' Expectation, Boosts Profit Guidance On Robust Demand
Wall Street Journal
Activist Investor Calls Out Alphabet To Follow Suit With Other Tech Giants, Cut Costs
Financial Times
Ford CEO Flags Need For More In-House Work Roles As Automaker Transitions Focus On EVs
Bloomberg
Meta Loses Yet Another Key India Official To Rival
Tesla Supplier Plans Second EV Battery Facility In US
Reuters
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
